Literature DB >> 23432821

Treatment-related lymphopenia in patients with stage III non-small-cell lung cancer.

Jian L Campian1, Xiaobu Ye, Malcolm Brock, Stuart A Grossman.   

Abstract

BACKGROUND: This study sought to estimate the severity, etiology, and clinical importance of treatment-related lymphopenia in patients with stage III non-small-cell lung cancer.
METHODS: Serial lymphocyte counts and survival were analyzed retrospectively in 47 patients accounting for known prognostic factors.
RESULTS: Total lymphocyte counts (TLCs) were normal before therapy and did not change following neoadjuvant chemotherapy. Following radiation, TLC fell by 67% (median 500 cells/mm(3), p <.00001). Multivariate analysis revealed an association between severe TLC and survival (HR 1.70, 95% CI: 0.8-3.6).
CONCLUSIONS: Rapid and severe lymphopenia occurred in 50% of patients following radiation which was associated with reduced survival.

Entities:  

Mesh:

Year:  2013        PMID: 23432821      PMCID: PMC4596242          DOI: 10.3109/07357907.2013.767342

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  17 in total

1.  Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide.

Authors:  Stuart A Grossman; Xiaobu Ye; Glenn Lesser; Andrew Sloan; Hetty Carraway; Serena Desideri; Steven Piantadosi
Journal:  Clin Cancer Res       Date:  2011-07-07       Impact factor: 12.531

2.  Active-specific immunotherapy for non-small cell lung cancer.

Authors:  Hauke Winter; Natasja K van den Engel; Margareta Rusan; Nina Schupp; Christian H Poehlein; Hong-Ming Hu; Rudolf A Hatz; Walter J Urba; Karl-Walter Jauch; Bernard A Fox; Dominik Rüttinger
Journal:  J Thorac Dis       Date:  2011-06       Impact factor: 2.895

3.  Colorectal cancer prognosis depends on T-cell infiltration and molecular characteristics of the tumor.

Authors:  Anna M Dahlin; Maria L Henriksson; Bethany Van Guelpen; Roger Stenling; Ake Oberg; Jörgen Rutegård; Richard Palmqvist
Journal:  Mod Pathol       Date:  2011-01-14       Impact factor: 7.842

Review 4.  Immune surveillance of tumors.

Authors:  Jeremy B Swann; Mark J Smyth
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

5.  Efficacy of cancer chemotherapy in relation to the pretreatment number of lymphocytes in patients with metastatic solid tumors.

Authors:  P Lissoni; F Brivio; L Fumagalli; G Messina; V Ghezzi; L Frontini; L Giani; M Vaghi; A Ardizzoia; G S Gardani
Journal:  Int J Biol Markers       Date:  2004 Apr-Jun       Impact factor: 2.659

6.  Severe lymphocytopenia and interstitial pneumonia in patients treated with paclitaxel and simultaneous radiotherapy for non-small-cell lung cancer.

Authors:  B Reckzeh; H Merte; K H Pflüger; R Pfab; M Wolf; K Havemann
Journal:  J Clin Oncol       Date:  1996-04       Impact factor: 44.544

7.  Combined modality trials of the Cancer and Leukemia Group B in stage III non-small-cell lung cancer: analysis of factors influencing survival and toxicity.

Authors:  M A Socinski; C Zhang; J E Herndon; R O Dillman; G Clamon; E Vokes; W Akerley; J Crawford; M C Perry; S L Seagren; M R Green
Journal:  Ann Oncol       Date:  2004-07       Impact factor: 32.976

8.  The etiology of treatment-related lymphopenia in patients with malignant gliomas: modeling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells.

Authors:  Susannah Yovino; Lawrence Kleinberg; Stuart A Grossman; Manisha Narayanan; Eric Ford
Journal:  Cancer Invest       Date:  2013-02       Impact factor: 2.176

9.  Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas.

Authors:  Isabelle Ray-Coquard; Claire Cropet; Martine Van Glabbeke; Catherine Sebban; Axel Le Cesne; Ian Judson; Olivier Tredan; Jaap Verweij; Pierre Biron; Inthidar Labidi; Jean-Paul Guastalla; Thomas Bachelot; David Perol; Sylvie Chabaud; Pancras C W Hogendoorn; Philippe Cassier; Armelle Dufresne; Jean-Yves Blay
Journal:  Cancer Res       Date:  2009-06-23       Impact factor: 12.701

10.  Strengths and weaknesses of immunotherapy for advanced non-small-cell lung cancer: a meta-analysis of 12 randomized controlled trials.

Authors:  Juan Wang; Ze-Hong Zou; Hong-Lin Xia; Jian-Xing He; Nan-Shan Zhong; Ai-Lin Tao
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

View more
  88 in total

1.  Lymphopenia after induction chemotherapy correlates with incomplete surgical resection in patients with advanced ovarian cancer.

Authors:  Yasunori Yoshino; Ayumi Taguchi; Maki Takao; Tomoko Kashiyama; Akiko Furusawa; Masaya Uno; Satoshi Okada; Nao Kino; Toshiharu Yasugi
Journal:  Int J Clin Oncol       Date:  2018-11-30       Impact factor: 3.402

2.  Association between severe treatment-related lymphopenia and progression-free survival in patients with newly diagnosed squamous cell head and neck cancer.

Authors:  Jian L Campian; Guneet Sarai; Xiaobu Ye; Shanthi Marur; Stuart A Grossman
Journal:  Head Neck       Date:  2014-04-15       Impact factor: 3.147

3.  Serial changes in lymphocyte subsets in patients with newly diagnosed high grade astrocytomas treated with standard radiation and temozolomide.

Authors:  Jian L Campian; Anna F Piotrowski; Xiaobu Ye; Frances T Hakim; Jeremy Rose; Xiao-Yi Yan; Yao Lu; Ronald Gress; Stuart A Grossman
Journal:  J Neurooncol       Date:  2017-07-29       Impact factor: 4.130

4.  Chemoradiation-Related Lymphopenia and Its Association with Survival in Patients with Squamous Cell Carcinoma of the Anal Canal.

Authors:  Grace Lee; Daniel W Kim; Vinayak Muralidhar; Devarati Mitra; Nora K Horick; Christine E Eyler; Theodore S Hong; Lorraine C Drapek; Jill N Allen; Lawrence S Blaszkowsky; Bruce Giantonio; Aparna R Parikh; David P Ryan; Jeffrey W Clark; Jennifer Y Wo
Journal:  Oncologist       Date:  2020-09-12

5.  T-Cell Lymphopenia in Patients with Advanced Thyroid Carcinoma Is Associated with Poor Prognosis.

Authors:  Katrin Rabold; Paul R Gielen; Esther D Kers-Rebel; Mihai G Netea; Jan W A Smit; Gosse J Adema; Romana T Netea-Maier
Journal:  Oncologist       Date:  2019-01-03

6.  Prognostic significance of pretreatment total lymphocyte count and neutrophil-to-lymphocyte ratio in extensive-stage small-cell lung cancer.

Authors:  Ryoko Suzuki; Steven H Lin; Xiong Wei; Pamela K Allen; James W Welsh; Lauren A Byers; Ritsuko Komaki
Journal:  Radiother Oncol       Date:  2018-02-02       Impact factor: 6.280

7.  Systemic depletion of lymphocytes following focal radiation to the brain in a murine model.

Authors:  Anna F Piotrowski; Thomas R Nirschl; Esteban Velarde; Lee Blosser; Sudipto Ganguly; Kathleen H Burns; Leo Luznik; John Wong; Charles G Drake; Stuart A Grossman
Journal:  Oncoimmunology       Date:  2018-05-09       Impact factor: 8.110

8.  Lymphopenia and its association with survival in patients with locally advanced cervical cancer.

Authors:  Emily S Wu; Titilope Oduyebo; Lauren P Cobb; Diana Cholakian; Xiangrong Kong; Amanda N Fader; Kimberly L Levinson; Edward J Tanner; Rebecca L Stone; Anna Piotrowski; Stuart Grossman; Kara Long Roche
Journal:  Gynecol Oncol       Date:  2015-11-11       Impact factor: 5.482

9.  Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons.

Authors:  Radhe Mohan; Amy Y Liu; Paul D Brown; Anita Mahajan; Jeffrey Dinh; Caroline Chung; Sarah McAvoy; Mary Frances McAleer; Steven H Lin; Jing Li; Amol J Ghia; Cong Zhu; Erik P Sulman; John F de Groot; Amy B Heimberger; Susan L McGovern; Clemens Grassberger; Helen Shih; Susannah Ellsworth; David R Grosshans
Journal:  Neuro Oncol       Date:  2021-02-25       Impact factor: 12.300

10.  Patterns of Radiation-Associated Lymphopenia in Children with Cancer.

Authors:  Miloš D Miljković; Stuart A Grossman; Xiaobu Ye; Susannah Ellsworth; Stephanie Terezakis
Journal:  Cancer Invest       Date:  2016-01-08       Impact factor: 2.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.